Sudarshan Pharma Industries Investor Presentation Highlights Expansion and Strong Financial Growth
Sudarshan Pharma Industries Ltd 路 Investor Presentation 路 07 Nov 2026, 9:54 pm
Sudarshan Pharma Industries Investor Presentation Highlights Expansion and Strong Financial Growth Sudarshan Pharma Industries reported consolidated FY'26 revenue of Rs 703.06 Cr, up 39.2% YoY, with EBITDA rising 25.4% YoY to Rs 49.3 Cr and PAT increasing 102% YoY to Rs 23.3 Cr. For Sep'26, half-year revenue stood at Rs 391.39 Cr with PAT of Rs 13.39 Cr. Strategic milestones include acquiring Rs 25.50 Cr capex from Srigen Lifesciences, securing GMP and ISO certifications for its Hyderabad API unit, proposing a $20 Mn FCCB allotment, and targeting over Rs 100 Cr in exports for FY'27.
Original exchange filing (PDF)
More announcements from Sudarshan Pharma Industries Ltd
- Pursuant to Regulation 30 and other applicable Regulations, if any, of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we inform .... 路 09 Nov 2026
- In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising .... 路 31 Oct 2026
- This is to inform you that the Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to .... 路 30 Oct 2026
- We are submitting herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- We are submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- Sudarshan Pharma Industries Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Fund raising. 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and Fund Raising 路 29 Oct 2026
- Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve i) Unaudited Standalone .... 路 29 Oct 2026
